An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
908 Devices to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
908 Devices Inc. (Nasdaq: MASS), a leader in handheld and desktop mass spectrometry, will participate in two upcoming virtual investor conferences. The first is the 11th Annual SVB Leerink Global Healthcare Conference, scheduled for February 17 at 5:40 a.m. PT. The second is the Cowen 42nd Annual Health Care Conference on March 8 at 8:10 a.m. PT. Investors can access live and archived webcasts via the company's website. 908 Devices aims to revolutionize laboratory mass spectrometry for critical applications in life sciences, bioprocessing, and more.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following virtual investor conferences.
11th Annual SVB Leerink Global Healthcare Conference Fireside Chat on Thursday, February 17th at 5:40 a.m. Pacific Time / 8:40 a.m. Eastern Time
Cowen 42nd Annual Health Care Conference Fireside Chat on Tuesday, March 8th at 8:10 a.m. Pacific Time / 11:10 a.m. Eastern Time
Interested parties may access a live and archived webcast of the virtual sessions on the “Investors” section of the company website at: www.908devices.com.
About 908 Devices
908 Devices Inc. (Nasdaq: MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics, and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.
What investor conferences is 908 Devices participating in?
908 Devices is participating in the 11th Annual SVB Leerink Global Healthcare Conference on February 17 and the Cowen 42nd Annual Health Care Conference on March 8.
When is the SVB Leerink Global Healthcare Conference?
The SVB Leerink Global Healthcare Conference is on February 17 at 5:40 a.m. Pacific Time.
When is the Cowen 42nd Annual Health Care Conference?
The Cowen 42nd Annual Health Care Conference is on March 8 at 8:10 a.m. Pacific Time.
How can I access the webcasts for the conferences?
Webcasts for the conferences can be accessed live and archived on the Investors section of the 908 Devices website.
What is the focus of 908 Devices' mass spectrometry technology?
908 Devices focuses on democratizing laboratory mass spectrometry for applications in life sciences, bioprocessing, and pharmaceuticals.